Avenue Therapeutics, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of neurologic diseases. The company product candidates include ATX-04, a small molecule therapy for the treatment of Pompe disease; and intravenous...
40 insider purchases on record · latest filing 2024-10-01.
Insiders have also filed 13 sale transactions at ATXI.